205 related articles for article (PubMed ID: 31929495)
1. Venous Sinus Stenting for Transverse Sinus Stenosis Associated with Leptomeningeal Carcinomatosis in a Patient with Epidermal Growth Factor Receptor-Mutated Lung Cancer: A Case Report.
Kawabata Y; Nakajima N; Miyake H; Yamamoto Y; Toda S; Terada Y; Takahashi M; Kurimoto M
Am J Case Rep; 2020 Jan; 21():e918488. PubMed ID: 31929495
[TBL] [Abstract][Full Text] [Related]
2. Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
Fukuda K; Otani S; Takeuchi S; Arai S; Nanjo S; Tanimoto A; Nishiyama A; Naoki K; Yano S
Cancer Sci; 2021 Sep; 112(9):3784-3795. PubMed ID: 34145930
[TBL] [Abstract][Full Text] [Related]
3. Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report.
Liu J; Jin B; Su H; Qu X; Liu Y
BMC Cancer; 2019 Jul; 19(1):702. PubMed ID: 31315676
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Hu X; Chen W; Li X; Zhao C; Zhang C; Xiong F; Wu H
Ann Palliat Med; 2019 Nov; 8(5):525-531. PubMed ID: 31865717
[TBL] [Abstract][Full Text] [Related]
5. Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility.
Koovor JM; Lopez GV; Riley K; Tejada J
Neuroradiol J; 2018 Oct; 31(5):513-517. PubMed ID: 29882475
[TBL] [Abstract][Full Text] [Related]
6. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis.
Radvany MG; Solomon D; Nijjar S; Subramanian PS; Miller NR; Rigamonti D; Blitz A; Gailloud P; Moghekar A
J Neuroophthalmol; 2013 Jun; 33(2):117-22. PubMed ID: 23502837
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation.
Okuno T; Arakawa S; Yoshida T; Ohe Y
Lung Cancer; 2020 May; 143():95-96. PubMed ID: 32209253
[No Abstract] [Full Text] [Related]
8. Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
Saboundji K; Auliac JB; Pérol M; François G; Janicot H; Marcq M; Dubos-Arvis C; Renault A; Guisier F; Odier L; Gervais R; Chouaïd C
Target Oncol; 2018 Aug; 13(4):501-507. PubMed ID: 30039345
[TBL] [Abstract][Full Text] [Related]
9. Unexpected occlusion of the contralateral transverse sinus after stenting for idiopathic intracranial hypertension.
Coffman SA; Singh J; Wolfe S; Fargen KM
Interv Neuroradiol; 2018 Dec; 24(6):718-721. PubMed ID: 29976107
[TBL] [Abstract][Full Text] [Related]
10. Bilateral transverse sinus stenosis causing intracranial hypertension.
Woodall MN; Nguyen KD; Alleyne CH; Macomson SD
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23964043
[TBL] [Abstract][Full Text] [Related]
11. Carcinomatosis under control by osimertinib in
Provenzano L; Cuccarini V; Platania M; Canziani L; Spagnoletti A; Doniselli FM; Eoli M; Prelaj A; Anghileri E
Tumori; 2021 Dec; 107(6):NP136-NP140. PubMed ID: 34727807
[TBL] [Abstract][Full Text] [Related]
12. Cerebral venous sinus thrombosis concomitant with leptomeningeal carcinomatosis, in a patient with epidermal growth factor receptor-mutated lung cancer.
Oda N; Sakugawa M; Bessho A; Horiuchi T; Hosokawa S; Toyota Y; Fukamatsu N; Nishii K; Watanabe Y
Oncol Lett; 2014 Dec; 8(6):2489-2492. PubMed ID: 25364413
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus.
Asif H; Craven CL; Siddiqui AH; Shah SN; Matloob SA; Thorne L; Robertson F; Watkins LD; Toma AK
J Neurosurg; 2018 Sep; 129(3):723-731. PubMed ID: 28984521
[TBL] [Abstract][Full Text] [Related]
14. Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
Yang JCH; Kim SW; Kim DW; Lee JS; Cho BC; Ahn JS; Lee DH; Kim TM; Goldman JW; Natale RB; Brown AP; Collins B; Chmielecki J; Vishwanathan K; Mendoza-Naranjo A; Ahn MJ
J Clin Oncol; 2020 Feb; 38(6):538-547. PubMed ID: 31809241
[TBL] [Abstract][Full Text] [Related]
15. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure?
Kelly LP; Saindane AM; Bruce BB; Ridha MA; Riggeal BD; Newman NJ; Biousse V
Clin Neurol Neurosurg; 2013 Aug; 115(8):1215-9. PubMed ID: 23219404
[TBL] [Abstract][Full Text] [Related]
16. Reversible transverse sinus collapse in a patient with idiopathic intracranial hypertension.
Onder H; Gocmen R; Gursoy-Ozdemir Y
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25979956
[TBL] [Abstract][Full Text] [Related]
17. Delayed relapse in pseudotumor cerebri due to new stenosis after transverse sinus stenting.
Winters HS; Parker G; Halmagyi GM; Mehta A; Atkins T
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26351311
[TBL] [Abstract][Full Text] [Related]
18. A school of red herring.
MacIntosh PW; Jain S; Moss HE; Volpe NJ; Alaraj A
Surv Ophthalmol; 2014; 59(6):664-70. PubMed ID: 24913331
[TBL] [Abstract][Full Text] [Related]
19. [Endovascular treatment of benign intracranial hypertension by stent placement in the transverse sinus. Therapeutic and pathophysiological considerations illustrated by a case report].
Métellus P; Levrier O; Fuentes S; Adetchessi T; Dufour H; Donnet A; Grisoli F
Neurochirurgie; 2005 May; 51(2):113-20. PubMed ID: 16107086
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
